Several brokerages have updated their recommendations and price targets on shares of Mazor Robotics (NASDAQ: MZOR) in the last few weeks:

  • 11/16/2017 – Mazor Robotics was upgraded by analysts at Zacks Investment Research from a “sell” rating to a “hold” rating. According to Zacks, “Mazor Robotics Ltd. is engaged in the development, production and marketing of medical devices for surgical procedures in the fields of orthopedics and neurosurgery. It offers Renaissance(TM), a surgical robotic system to conduct spine surgeries with less radiation. The company operates in the United States, Eastern Europe, Western Europe and Asia. Mazor Robotics Ltd. is based in Caesarea, Israel. “
  • 11/9/2017 – Mazor Robotics was downgraded by analysts at Zacks Investment Research from a “hold” rating to a “sell” rating. According to Zacks, “Mazor Robotics Ltd. is engaged in the development, production and marketing of medical devices for surgical procedures in the fields of orthopedics and neurosurgery. It offers Renaissance(TM), a surgical robotic system to conduct spine surgeries with less radiation. The company operates in the United States, Eastern Europe, Western Europe and Asia. Mazor Robotics Ltd. is based in Caesarea, Israel. “
  • 11/8/2017 – Mazor Robotics was upgraded by analysts at TheStreet from a “d” rating to a “c-” rating.
  • 11/7/2017 – Mazor Robotics had its “hold” rating reaffirmed by analysts at Needham & Company LLC. They wrote, “MZOR beat consensus revenue and EPS though we note that it had preannounced that it had new orders for 22 systems and revenue of ~$17.2M in 3Q17 on 10/9/17. There were 19 systems delivered in 3Q17, which met our post- preannouncement estimate of 19 and was up from 14 systems in 2Q17. We note that MDT assumed full responsibility for the distribution of the Mazor X system on 9/18/17. MZOR’s operating margin was lower than expected as MZOR increased investments in sales and marketing activities. The MDT agreement has accelerated MZOR’s growth rate but we believe that this is now more than priced into MZOR shares.””
  • 10/30/2017 – Mazor Robotics was given a new $67.00 price target on by analysts at Ladenburg Thalmann Financial Services. They now have a “buy” rating on the stock.
  • 10/19/2017 – Mazor Robotics was downgraded by analysts at Barclays PLC from an “equal weight” rating to an “underweight” rating. They now have a $34.00 price target on the stock, down previously from $55.00.
  • 10/13/2017 – Mazor Robotics was downgraded by analysts at Zacks Investment Research from a “strong-buy” rating to a “hold” rating. According to Zacks, “Mazor Robotics Ltd. is engaged in the development, production and marketing of medical devices for surgical procedures in the fields of orthopedics and neurosurgery. It offers Renaissance(TM), a surgical robotic system to conduct spine surgeries with less radiation. The company operates in the United States, Eastern Europe, Western Europe and Asia. Mazor Robotics Ltd. is based in Caesarea, Israel. “
  • 10/11/2017 – Mazor Robotics had its “hold” rating reaffirmed by analysts at Barclays PLC. They now have a $34.00 price target on the stock.

Mazor Robotics Ltd. (MZOR) traded down $0.73 on Tuesday, reaching $59.40. The company’s stock had a trading volume of 368,600 shares, compared to its average volume of 415,867. Mazor Robotics Ltd. has a 52 week low of $20.50 and a 52 week high of $65.97.

Mazor Robotics Ltd is an Israel-based medical device company that develops and markets surgical guidance systems and complementary products. It develops computerized and imaging-based systems in the field of spine surgery. Its products include: Renaissance Surgical Guidance System, which enables surgeons to advance from freehand surgical procedures to guided procedures, as well as Food and Drug Administration (FDA)-cleared and European Conformity (CE)-marked Renaissance System, used in spine surgeries, whether open or minimally invasive, for a number of clinical indications.

Receive News & Stock Ratings for Mazor Robotics Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics Ltd and related stocks with our FREE daily email newsletter.